Cyclin-dependent kinases inhibitors improve antimetabolite drug potency depending on SAMHD1 expression
Por:
Felip, E, Badia, R, Margeli, M, Castellvi, M, Quiroga, V, Teruel, I, Cirauqui, B, Romeo, M, Ezeonwumelu, IJ, Riveira-Munoz, E, Este, J and Ballana, E
Publicada:
1 feb 2020
Resumen:
Filiaciones:
:
Hosp Badalona Germans Trias & Pujol, ICO, B ARGO Grp, Med Oncol Serv, Badalona, Spain
:
Inst & IrsiCaixa & Hlth Res Inst Germans Trias &, AIDS Res Inst, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, ICO, B ARGO Grp, Med Oncol Serv, Badalona, Spain
:
Inst & IrsiCaixa & Hlth Res Inst Germans Trias &, AIDS Res Inst, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, ICO, B ARGO Grp, Med Oncol Serv, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, ICO, B ARGO Grp, Med Oncol Serv, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, ICO, B ARGO Grp, Med Oncol Serv, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, ICO, B ARGO Grp, Med Oncol Serv, Badalona, Spain
:
Inst & IrsiCaixa & Hlth Res Inst Germans Trias &, AIDS Res Inst, Badalona, Spain
:
Inst & IrsiCaixa & Hlth Res Inst Germans Trias &, AIDS Res Inst, Badalona, Spain
:
Inst & IrsiCaixa & Hlth Res Inst Germans Trias &, AIDS Res Inst, Badalona, Spain
:
Inst & IrsiCaixa & Hlth Res Inst Germans Trias &, AIDS Res Inst, Badalona, Spain
|